Diabetic Medicine SCIE

國際簡稱：DIABETIC MED 參考譯名：糖尿病醫(yī)學

主要研究方向：醫(yī)學-內(nèi)分泌學與代謝非預(yù)警期刊審稿周期：一般,3-6周

《糖尿病醫(yī)學》(Diabetic Medicine)是一本由Wiley-Blackwell Publishing Ltd出版的以醫(yī)學-內(nèi)分泌學與代謝為研究特色的國際期刊，發(fā)表該領(lǐng)域相關(guān)的原創(chuàng)研究文章、評論文章和綜述文章，及時報道該領(lǐng)域相關(guān)理論、實踐和應(yīng)用學科的最新發(fā)現(xiàn)，旨在促進該學科領(lǐng)域科學信息的快速交流。該期刊是一本未開放期刊，近三年沒有被列入預(yù)警名單。

3區(qū) 中科院分區(qū)
Q2 JCR分區(qū)
191 年發(fā)文量
3.2 IF影響因子
未開放 是否OA
132 H-index
1984 創(chuàng)刊年份
Monthly 出版周期
English 出版語言

Diabetic Medicine, the official journal of Diabetes UK, is published monthly simultaneously, in print and online editions.

The journal publishes a range of key information on all clinical aspects of diabetes mellitus, ranging from human genetic studies through clinical physiology and trials to diabetes epidemiology. We do not publish original animal or cell culture studies unless they are part of a study of clinical diabetes involving humans. Categories of publication include research articles, reviews, editorials, commentaries, and correspondence. All material is peer-reviewed.

We aim to disseminate knowledge about diabetes research with the goal of improving the management of people with diabetes. The journal therefore seeks to provide a forum for the exchange of ideas between clinicians and researchers worldwide. Topics covered are of importance to all healthcare professionals working with people with diabetes, whether in primary care or specialist services.

Surplus generated from the sale of Diabetic Medicine is used by Diabetes UK to know diabetes better and fight diabetes more effectively on behalf of all people affected by and at risk of diabetes as well as their families and carers.”

[ 查看全部 ]

投稿咨詢加急咨詢

Diabetic Medicine期刊信息

ISSN：0742-3071
出版語言：English
是否OA：未開放
E-ISSN：1464-5491
出版地區(qū)：ENGLAND
是否預(yù)警：否
出版商：Wiley-Blackwell Publishing Ltd
出版周期：Monthly
創(chuàng)刊時間：1984
開源占比：0.2925
Gold OA文章占比：43.08%
OA被引用占比：0.2633...
出版國人文章占比：0.01
出版撤稿占比：0
研究類文章占比：79.58%

Diabetic Medicine CiteScore評價數(shù)據(jù)（2024年最新版）

CiteScore

SJR

SNIP

CiteScore 指數(shù)

7.2

1.303

1.219

學科類別	分區(qū)	排名	百分位
大類：Medicine 小類：Internal Medicine	Q1	33 / 167	80%
大類：Medicine 小類：Endocrinology, Diabetes and Metabolism	Q2	64 / 244	73%
大類：Medicine 小類：Endocrinology	Q2	43 / 128	66%

名詞解釋：CiteScore 是衡量期刊所發(fā)表文獻的平均受引用次數(shù)，是在 Scopus 中衡量期刊影響力的另一個指標。當年CiteScore 的計算依據(jù)是期刊最近4年（含計算年度）的被引次數(shù)除以該期刊近四年發(fā)表的文獻數(shù)。例如，2022年的 CiteScore 計算方法為：2022年的 CiteScore =2019-2022年收到的對2019-2022年發(fā)表的文件的引用數(shù)量÷2019-2022年發(fā)布的文獻數(shù)量注：文獻類型包括：文章、評論、會議論文、書籍章節(jié)和數(shù)據(jù)論文。

Diabetic Medicine中科院評價數(shù)據(jù)

中科院 2023年12月升級版

Top期刊	綜述期刊	大類學科		小類學科
否	否	醫(yī)學	3區(qū)	ENDOCRINOLOGY & METABOLISM 內(nèi)分泌學與代謝	3區(qū)

中科院 2022年12月升級版

Top期刊	綜述期刊	大類學科		小類學科
否	否	醫(yī)學	3區(qū)	ENDOCRINOLOGY & METABOLISM 內(nèi)分泌學與代謝	3區(qū)

中科院 2021年12月舊的升級版

Top期刊	綜述期刊	大類學科		小類學科
否	否	醫(yī)學	2區(qū)	ENDOCRINOLOGY & METABOLISM 內(nèi)分泌學與代謝	3區(qū)

中科院 2021年12月基礎(chǔ)版

Top期刊	綜述期刊	大類學科		小類學科
否	否	醫(yī)學	3區(qū)	ENDOCRINOLOGY & METABOLISM 內(nèi)分泌學與代謝	3區(qū)

中科院 2021年12月升級版

Top期刊	綜述期刊	大類學科		小類學科
否	否	醫(yī)學	2區(qū)	ENDOCRINOLOGY & METABOLISM 內(nèi)分泌學與代謝	3區(qū)

中科院 2020年12月舊的升級版

Top期刊	綜述期刊	大類學科		小類學科
否	否	醫(yī)學	3區(qū)	ENDOCRINOLOGY & METABOLISM 內(nèi)分泌學與代謝	3區(qū)

Diabetic Medicine JCR評價數(shù)據(jù)（2023-2024年最新版）

按JIF指標學科分區(qū)	收錄子集	分區(qū)	排名	百分位
學科：ENDOCRINOLOGY & METABOLISM	SCIE	Q2	81 / 186	56.7%

按JCI指標學科分區(qū)	收錄子集	分區(qū)	排名	百分位
學科：ENDOCRINOLOGY & METABOLISM	SCIE	Q2	87 / 186	53.49%

Diabetic Medicine歷年數(shù)據(jù)統(tǒng)計

影響因子

中科院分區(qū)

Diabetic Medicine中國學者發(fā)文選摘

1、MicroRNA-7a-5p ameliorates diabetic peripheral neuropathy by regulating VDAC1/JNK/c-JUN pathway
Author: Jiao, Yang; Zhang, Yue-Hua; Wang, Chun-Yan; Yu, Yang; Li, Yi-Ze; Cui, Wei; Li, Qing; Yu, Yong-Hao

Journal: DIABETIC MEDICINE. 2023; Vol. 40, Issue 1, pp. -. DOI: 10.1111/dme.14890
2、Prevalence and risk factors of cognitive frailty in community-dwelling older adults with diabetes: A systematic review and meta-analysis
Author: Lyu, Qiong; Guan, Chi-Xun; Kong, Ling-Na; Zhu, Jia-Lu

Journal: DIABETIC MEDICINE. 2023; Vol. 40, Issue 1, pp. -. DOI: 10.1111/dme.14935
3、Lysine demethylase KDM5B down-regulates SIRT3-mediated mitochondrial glucose and lipid metabolism in diabetic neuropathy
Author: Jiao, Yang; Li, Yi-Ze; Zhang, Yue-Hua; Cui, Wei; Li, Qing; Xie, Ke-Liang; Yu, Yang; Yu, Yong-Hao

Journal: DIABETIC MEDICINE. 2023; Vol. 40, Issue 1, pp. -. DOI: 10.1111/dme.14964
4、The vicious circle of UHRF1 down-regulation and KEAP1/NRF2/HO-1 pathway impairment promotes oxidative stress-induced endothelial cell apoptosis in diabetes
Author: Guo, Zi; Wan, Xinxing; Luo, Yufang; Liang, Fang; Jiang, Siwei; Yuan, Xiuhong; Mo, Zhaohui

Journal: DIABETIC MEDICINE. 2023; Vol. 40, Issue 4, pp. -. DOI: 10.1111/dme.15026
5、Ascorbic acid protects retinal pigment epithelial cells from high glucose by inhibiting the NF-kappa B signal pathway through MALAT1/IGF2BP3 axis
Author: Tian, Yanming; Cheng, Wubo; Wang, Haiyan; Zeng, Chengcheng; Chen, Xueyi

Journal: DIABETIC MEDICINE. 2023; Vol. 40, Issue 5, pp. -. DOI: 10.1111/dme.15050
6、Applications of continuous glucose monitoring across settings and populations: Report from the 23rd Hong Kong diabetes and cardiovascular risk factors-East meets west symposium
Author: Oliver, Nick; Chow, Elaine; Luk, Andrea O. Y.; Murphy, Helen R.

Journal: DIABETIC MEDICINE. 2023; Vol. 40, Issue 5, pp. -. DOI: 10.1111/dme.15038
7、Identification of signalling downstream of the transcription factor forkhead box protein M1 that protects against endoplasmic reticulum stress in a diabetic foot ulcer model
Author: Peng, Weixia; Zhu, Ting; Xiang, Guangda; Ding, Ting; Zhao, Jun; Xiong, Dan; Zhong, Yaqin; Zhang, Youqi

Journal: DIABETIC MEDICINE. 2023; Vol. , Issue , pp. -. DOI: 10.1111/dme.15051
8、The interface targeting hnRNPA2B1 regulates the repression of transthyretin against human retinal microvascular endothelial cells in high-glucose environment
Author: Tian, Yikun; Ye, Lu; Shao, Jun; Xin, Yu

Journal: DIABETIC MEDICINE. 2023; Vol. , Issue , pp. -. DOI: 10.1111/dme.15125